BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Consumer Health

Hyphens Pharma Launches Winlevi® in Singapore and Malaysia, Ushering in a New Era of Acne Treatment in Southeast Asia

Hyphens Pharma Pte. Ltd., a subsidiary of SGX Catalist-listed Hyphens Pharma International Limited, Singapore’s leading specialty pharmaceutical...

July 18, 2025 | News

Using NLP-Driven Decision Support in Emergency Health Assistance

According to the US Department of Transportation, over 40,000 lives were lost in roadway deaths in 2023. The CDC reports that the country saw appro...

July 14, 2025 | News

Southeast Asia Poised to Lead AI-Driven Healthcare Transformation Amid Rising Cross-Border Collaboration

The Southeast Asia (SEA) region’s role in healthcare innovation, long bolstered by Singapore’s commitment to serve as a g...

July 01, 2025 | Opinion | By Chu Canh Chieu, FPT Software Managing Director of Global Healthcare Center, FPT Corporation

Novo Nordisk Launches Anti-Obesity Drug Wegovy in India for Chronic Weight Management and Cardiovascular Risk Reduction

Danish pharmaceutical major Novo Nordisk has officially launched its anti-obesity therapy Wegovy in India. The once-weekly injectable treatment is approved...

June 24, 2025 | News

Immuno Cure and PharmaJet Partner on Needle-Free HIV Therapeutic Vaccine Study in Hong Kong

Immuno Cure BioTech ("Immuno Cure"), a clinical-stage biotechnology group based in Hong Kong Science Park, is pleased to announce its upcoming collaboratio...

June 20, 2025 | News

MSD Launches Phase 3 MOBILIZE-1 Trial for Single-Dose Dengue Vaccine V181 in Asia-Pacific

MOBILIZE-1 is the first Phase 3 study being initiated for V181 as part of a planned robust clinical development program Study will evaluate a single dos...

June 16, 2025 | News

Singapore Approves Astellas’ VEOZA™ (Fezolinetant) for Moderate to Severe Menopausal Vasomotor Symptoms

Astellas Singapore has announced that the Health Sciences Authority (HSA) of Singapore has approved VEOZA™ (fezolinetant) 45 mg for the treatment of ...

June 04, 2025 | News

XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders

XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell the...

June 03, 2025 | News

CirCode Secures FDA IND Clearance for World’s First Circular RNA Therapy in Ischemic Heart Disease

Shanghai CirCode Biomed Co. Ltd. (CirCode), an innovative biotech company pioneering circular RNA therapies, recently announced that its leading pipeline H...

June 02, 2025 | News

Docquity’s Christophe Meugnier on Powering Patient Support with Digital Precision Across Southeast Asia

In this interview with BioPharma APAC, Christophe Meugnier, Chief Commercial Officer and General Manager of Vietnam & Thailand at Do...

May 19, 2025 | Interview

ASPIRE Launches Fertility Health Awareness Drive Under New President Dr Haroon Latif

The Asia Pacific Initiative on Reproduction (ASPIRE) – the peak body harnessing expertise in assisted conception throughout the region – will e...

May 12, 2025 | News

Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific

Vision health is emerging as a critical but under-addressed component of public health in Asia Pacific. In a region where populations are rapidly ageing an...

May 09, 2025 | Expert Insight

Siemens Healthineers Launches MAMMOMAT B.brilliant to Advance Early Breast Cancer Detection in Indonesia

Breast cancer remains one of the leading health concerns in Indonesia and ranks as the third deadliest cancer after lung and liver cancer. According to the...

May 02, 2025 | News

Roche Survey Calls for Immediate Action as Asia Pacific Faces Worsening Vision Health Crisis

Asia Pacific bears nearly two-thirds of the global burden of moderate-to-severe vision impairment. Although 90 percent of vision impairment is preventable ...

April 24, 2025 | News

Stay Connected